From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Open accessThe DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Abstract
The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control. In cancer, the lymph nodes that drain solid tumours are a primary site of metastasis, and recent studies have suggested intrinsic links between lymphatic function, lipid deposition, obesity and atherosclerosis. Advances in the current understanding of the role of the lymphatics in pathological change and immunity have driven the recognition that lymph-targeted delivery has the potential to transform disease treatment and vaccination. In addition, the design of lymphatic delivery systems has progressed from simple systems that rely on passive lymphatic access to sophisticated structures that use nanotechnology to mimic endogenous macromolecules and lipid conjugates that 'hitchhike' onto lipid transport processes. Here, we briefly summarize the lymphatic system in health and disease and the varying mechanisms of lymphatic entry and transport, as well as discussing examples of lymphatic delivery that have enhanced therapeutic utility. We also outline future challenges to effective lymph-directed therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lymphatic route also exposes lymph-resident tissues, including the mesenteric lymph nodes and circulating lymphocytes, to drug concentrations far higher than those measured in systemic plasma, a property now exploited deliberately for lymph-targeted therapy but also a source of disconnect between plasma-based scaling and tissue exposure [32].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
On the Absorption of Fluids from the Connective Tissue Spaces
Starling, E. H. (1896) · The Journal of Physiology · doi:10.1113/jphysiol.1896.sp000596 · Cited by 2,148
CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
Cited by
Items 601–653 of 653
Curry, S. H., & Whelpton, R. (2022) · Wiley eBooks · doi:10.1002/9781119589181.ch2
Challenges and Opportunities in the Delivery of Oral Anticancer Therapeutics
Rahman, M., Alam, K., Daniel, S., Alam, A., & Beg, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_1
Investigation of antigen loading in synthetic peptide vaccines for cancer immunotherapy
Cooney, T. R. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.22783022
Development of Analytical Procedures for the Characterization of Polypeptide-Based Nanoconjugates
Đorđević, S. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194554
Drug- Phospholipid complex: A novel strategy for Lymphatic Filariasis treatment
Vyas, A., Kumar, N., & Jain, V. (2023) · International Journal of Technology · doi:10.52711/2231-3915.2023.00012
Parshin, D., Mikhaylichenko, V. Y., Bondarenko, N., Gorbunov, A., Voronkov, D., Voronov, A., BEZRUKOV, O. F., Trofimov, P., & Stul, T. (2024) · Archiv Euromedica · doi:10.35630/2024/14/2.203
Parshin, D., Mikhaylichenko, V. Y., Bondarenko, N., Gorbunov, A., Voronkov, D., Voronov, A., BEZRUKOV, O. F., & Trofimov, P. (2024) · Archiv Euromedica · doi:10.35630/2024/14/2.222
Singh, V. P., Pillai, A. N., Rajalingamgari, P., & Khatua, B. (2024) · Springer eBooks · doi:10.1007/978-981-97-3132-9_6
Nanoparticles in Targeting Lymphatic System for Cancer Treatment
Nayak, S., Karmakar, A., & Kumar, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-64828-1_17
Challenges and Limitations of the Lymphatic Drug Delivery Systems
Khademi, Z., Mottaghi-Dastjerdi, N., Morad, H., Hedayati, N., & Sharafi, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-64828-1_22
Matthews, M. M., Kim, T. G., Kim, K. Y., Meshcheryakov, V., Iha, H. A., Tamai, M., Sasaki, D., Laurino, P., Toledo‐Patiño, S., Collins, M. K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76377-y
Lipid-drug conjugates: conjugation methods and therapeutic benefits
Singha, L. R., Das, S., & Das, M. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33382-8.00002-9
Siggins, M. K., Li, H. K., Huse, K. K., Pearson, M., Openshaw, P., Jackson, D. G., & Sriskandan, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.21.649860
Li, C.-Y., Sun, J., Xu, J., Wu, M., Li, X.-J., Liu, Z., Dong, Q., Sun, Y., & Ding, Y.-H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1580883
Kojima, C. (2025) · Polymer Journal · doi:10.1038/s41428-025-01115-8
Parlow, J., Sandegren, A., Güler, R., Karlberg, I., Frejd, F. Y., Sjögren, H., & Hansson, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149322 · Cited by 1
Abishek, K. G., Padil, V. V. T., Sarangi, P. K., Gupta, G., Sahebkar, A., Patil, U. K., Kesharwani, P., & Dandela, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33548-8.01018-1
Dose optimization of lymph node-targeted cyclosporine-A for lupus-driven vasculopathy
Babalola, K. T., Ganugula, R., Arora, M., Anderson, D., Agarwal, S. K., Mohan, C., Mehrara, B. J., & Kumar, M. N. V. R. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114553
Dai, Y., Yu, X., Leng, Y., Peng, X., Wang, J., Zhao, Y., Chen, J., & Zhang, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26607904
Lymphatic Imaging Techniques: Evaluation of the Peripheral Lymphatic System
Loening, A. M., Yang, J., Sibley, R. C., Kim, T. H., Nguyen, D. H., Dou, Q., & Tsai, L. L. (2026) · Seminars in Roentgenology · doi:10.1016/j.ro.2026.150979
Jentschura, F. A., Breidenbach, L., Mezler, M., Koziolek, M., & Ye, D. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126795 · Cited by 1
タンパク質発現の投与部位/肝臓比の向上を目的とした局所投与用mRNA-コレステロール低含有脂質ナノ粒子の開発に関する研究
Kawaguchi, M. (2023) · Institutional Repositories DataBase (IRDB)
Camara, A. (2019) · theses.fr (ABES) · doi:10.70675/9e8b443az19ecz4c6fz8462z72afbb2236e3
Nanoformulation d'une molécule antirétrovirale pour le ciblage des réservoirs du VIH-1
Quaillet, M. (2018) · theses.fr (ABES) · doi:10.70675/bf2ed959z99f4z4d77zbb0ez1bd1d150b365
PBPK modeling of doxorubicin-loaded polymeric nanoparticles : potential for clinical translation
Chao, F.-C. (2023) · theses.fr (ABES) · doi:10.70675/7bcf6d06za15fz452fz9b70z8697a902c896
Boosting long-term immunity with bioengineered nanovaccines
Li, M., Sun, W., Zheng, X., Gao, P., Zhang, L., Zhu, D., & Li, F. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114923
Li, T., Wang, Y., Xin, Z., Si, H., Kang, Y. Y., Chen, H., & Bai, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1773881
Chen, L., Xu, Y., Yang, S., Chen, N., Gao, J., & Lin, H. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101163
Hu, Z., & Wood, K. (2026) · PLOS complex systems. · doi:10.1371/journal.pcsy.0000113
S, D. B., & Prabha, A. (2026) · PAIN JOINTS SPINE · doi:10.1922/pjs.16.3s.2026.607
Oral delivery of topoisomerase I inhibitors: From biopharmaceutical barriers to clinical translation
Taheri, A., Bremmell, K. E., Hickey, S. M., Joyce, P., & Prestidge, C. A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115166
Lipidation of the KV1.3 blocking peptide HsTX1[R14A] alters its pharmacokinetics and biodistribution
Lin, L., Mitchell, T. R., Sanches, K., Abdallah, M., Ren, Y., Farooq, M. A., Song, H., Qu, J., Chen, Z., Nardo, W. D., et al. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127198
Self-citationShen, Q., Ma, Y., Zhang, C., Guo, Y., & Qin, X. (2026) · Biomolecules · doi:10.3390/biom16081095
rHuPH20 Enhances Extravascular Delivery of mRNA Lipid Nanoparticles in Mice and Minipigs
Nolan, R. P., Printz, M. A., Kang, D. W., Connor, R. J., Wang, Y., Liu, L., & Wahl, C. (2026) · Nucleic Acid Therapeutics · doi:10.1177/21593337261479163 · Cited by 1
Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development
Gowans, C., Khedr, A., Georgiou, P. G., Arik, N., Sen, O., Rannard, S. P., McDonald, T. O., & Tapeinos, C. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71625
Hu, Y., Zhou, Z., Wang, L., Cheng, J., Yu, T., Pan, Y., Chen, M., Chen, B., Shi, J., Wang, Y., et al. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.6c08726
Osman, T. M., El-Marakby, E. M., El-Gogary, R. I., & Awad, G. A. S. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10912-4
From endovascular therapy to perivascular therapy: A new concept and perspective
Wang, Z., Shi, P., Zhou, Y.-J., Guo, W., Cao, Y., Mao, S., & Teng, G.-J. (2026) · EngMedicine · doi:10.1016/j.engmed.2026.100164
Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract
Wen, A. C. A., Chen, X., & Zhang, W. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04211-3 · Cited by 1
Self‐Assembling Peptide‐Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy
Wu, Y., Hu, J., Hu, Y., Li, W., Rong, L., Li, R., Yao, Y., Hu, L., Wang, X., Zhang, B., et al. (2026) · Advanced Science · doi:10.1002/advs.77632
A systemic-absorption-blocked (SEAL) nanoplatform for mRNA-based local immunotherapy
Qiu, Y., Li, R., Duan, X., Li, Z., Cai, Y., Zhou, Q., Zhou, T., Liu, X., & Xuefei, Z. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115430
Lin, M.-Y., Zhang, T., Wang, L., Wang, Q., Wang, S.-Y., Jiang, N., Wang, Y., Zheng, L.-L., Wang, R., Yang, C.-Z., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218881
Zhao, L., An, S., Gao, M., Shen, C., Li, M., Li, Y., Liu, N., Chen, J., Wan, W., Yin, L., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103094
Yi, H., Zhang, Y., Jia, H., Chen, J., & Huang, Z. (2026) · Nanomaterials · doi:10.3390/nano16201278
Adarkar, R., Dessai, A. D., Viswambharan, V. L., Ramesh, M. M., Lobo, R., Tippavajhala, V. K., & Subraya, C. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.109018
George, B., Singh, H., Devoe, C., Chung, V. M., Hosein, P. J., Hendifar, A., Kim, D. W., Valerin, J. B., Bekaii‐Saab, T., Cardin, D. B., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04734-7 · Cited by 1
Wu, B., Xu, X., Jin, P., Chen, Y., Fang, X., Yue, S., Wang, G., 周嘉嘉, Wang, H., & Huang, P. (2026) · ACS Nano · doi:10.1021/acsnano.6c10137
Li, P., Abdallah, M., Yao, Y., Mugan, R. S., Payne, T. J., Fabb, S. A., Pouton, C. W., & Trevaskis, N. L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115491
Self-citationFurther Insights Into the Mechanisms of Lymph Node Metastasis
Nathanson, D. S., O’Melia, M. J., Rosso, K. C. F., Wood, I. S., Lall, D., & Bui, J. T. (2026) · Cancer Medicine · doi:10.1002/cam4.72404
Zhao, W., Zhang, S., Deng, Y., 張雪媃, Wu, J., Jiang, L., Deng, C., & Qi, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.2007671
Effects Of Lymphocyte Trafficking on Antiretroviral Drug Distribution within the Lymph NodePreprint
Anam, S., Donzanti, M., Dang, A., Paryad-Zanjani, S., Piovoso, M. J., Gleghorn, J. P., & Zurakowski, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.28.762578
Dinakar, Y. H., Ganugula, R., Sood, A. K., Kumar, M. N. V. R., & Arora, M. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115988
Metadata
- Authors
- Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 14
- Issue
- 11
- Pages
- 781-803
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2204416339
- Cited by
- 654
- References
- 287
- Citations by year
- 2026: 43 · 2025: 59 · 2024: 66 · 2023: 71 · 2022: 76 · 2021: 95 · 2020: 81 · 2019: 61 · 2018: 42 · 2017: 38 · 2016: 20 · 2015: 1
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
- research.monash.edu
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- lymph node targeting, lymphatic drug delivery, lymphatic system, nanotechnology, lipid conjugates, prophylactic vaccination, therapeutic vaccination, tolerance induction, metastasis, lymph nodes, obesity, atherosclerosis, bioavailability, drug development
- MeSH terms
- Animals, Biological Transport, Humans, Lymphatic System, Neoplasms, Prodrugs, Drug Delivery Systems, Lymphatic Vessels, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.